Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Glaukos’ Epioxa to redefine treatment for keratoconus after a decade without new therapies, says GlobalData

FDA’s recent approval for Epioxa (IVMED-80) marks a landmark moment in ophthalmology, introducing the first and only incision-free, topical drug therapy for keratoconus. Developed by Glaukos Corporation, Epioxa is expected to transform keratoconus care from a procedure-based model to a pharmacologic one, emphasizing accessibility and patient comfort after nearly a decade without new treatment options, […]
Read more

Metsera takeover battle reflects Novo Nordisk and Pfizer push to challenge Lilly’s obesity drug dominance, says GlobalData

Following the news that Novo Nordisk made an unsolicited acquisition bid for US-based obesity biotech Metsera Therapeutics, which was subsequently rejected by Pfizer, but designated by Metsera as a “Superior Company Proposal” to the one previously agreed between Metsera and Pfizer: Jay Patel, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers […]
Read more

Expanded low- and no-alcohol drink ranges key to entice younger generations to splash out over Christmas period, says GlobalData

Retailers must extend and elevate their low- and no-alcohol ranges over the Christmas period to capture a larger share of young consumers’ festive spending. Gen Z’s changing social attitudes mean such drink options are viewed as desirable choices, rather than substitutes for alcoholic beverages, and over four-fifths of them* say low- and no-alcohol drinks allow them to prioritize health & […]
Read more

US tariffs to complicate renewable energy transition across Americas, says GlobalData

The Donald Trump administration’s implementation of reciprocal tariffs is particularly evident in sectors deemed critical to national interests, such as energy, where maintaining stable supply chains is essential. As the US tariff landscape continues to evolve, the implications for energy markets across the Americas are profound. Designed to bolster domestic manufacturing and reduce reliance on […]
Read more

Top 20 global biopharmaceutical companies report 4% market capitalization growth in Q3 2025, reveals GlobalData

The top 20 global biopharmaceutical companies experienced mixed individual market capitalization performances in Q3 2025, with those experiencing robust pipeline progress reaping success. This resulted in a 4% quarter-on-quarter (QoQ) increase in their combined market capitalization from $3.7 trillion on 30 June 2025 to $3.8 trillion on 30 September 2025, reveals GlobalData, a leading data […]
Read more

Agentic and GenAI adoption across capital markets rises but financial institutions temper expectations, finds Celent, a GlobalData company

54% of survey respondents expect to have Agentic AI in production next year GenAI sentiment down YoY as industry focuses on ROI Financial institutions across capital markets indicates respondents are taking a reality check when it comes to expectations around GenAI and Agentic AI. While financial institutions quickly implemented the more straight-forward use cases such […]
Read more

US VC funding value surges 84% YoY during Q1-Q3 2025 despite fall in deal volume, finds GlobalData

The US venture capital (VC) landscape demonstrated remarkable resilience in the first three quarters (Q1-Q3) of 2025, with total funding value soaring by an impressive 84% year-over-year, even as deal volume experienced a modest decline of around 3%, according to GlobalData, a leading data and analytics company. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The […]
Read more

Vietnam card payments market to grow by 5% in 2025 to reach $48.7 billion, forecasts GlobalData

The card payments market in Vietnam is expected to grow by 5% to reach VND1.2 quadrillion ($48.7 billion) in 2025, supported by the constant consumer shift towards non-cash payments. While cash remains dominant, strong government support, growing card penetration, and evolving consumer preferences are supporting the country’s transition to a less cash-dependent economy and reshaping […]
Read more

Gen AI and agentic AI drive next stage in trade finance digitization, says Celent, a GlobalData company

Trade finance remains slowed by manual processes, paper documents, and persistent fraud, delaying operations by days and increasing risk. Emerging generative AI (GenAI) and agentic AI applications offer banks an opportunity to digitize critical workflows, improve efficiency, strengthen risk detection, and enhance customer experience, potentially transforming trade finance operations and creating a competitive edge in […]
Read more

Japan ultrasound systems market to reach $1.265 billion in 2034, forecasts GlobalData

Japan’s medical imaging field is progressing steadily with broader adoption of ultrasound diagnostic systems. Within this context, Japan’s ultrasound systems market is projected to reach $1.265 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Ultrasound Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to […]
Read more

Global solar PV modules and inverters market to reach $115.8 billion by 2030, forecasts GlobalData

The global solar PV modules and inverters market is forecast to reach $115.8 billion by 2030, largely driven by the Asia-Pacific (APAC) region with its strong policy initiatives, ambitious renewable energy targets, large-scale investments, rapid urbanization, declining technology costs, and expanding solar manufacturing and innovation in major economies, according to  GlobalData, a leading data and […]
Read more

Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy, says GlobalData

Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in patients with Staphylococcus aureus bacteremia (SAB) in a Phase IIa trial, reinforcing the growing clinical promise of bacteriophage-based treatments. The findings highlight the therapy’s potential to address antibiotic resistance and provide a new treatment option for patients with serious bloodstream infections, says GlobalData, a leading […]
Read more
1 … 41 42 43 44 45 … 777